Private Equity Firms Set Sights on German Nutraceutical Giant Orthomol

In a significant development within the health and wellness sector, several private equity firms are reportedly eyeing Orthomol, a well-known German manufacturer of vitamin supplements. This strategic interest comes as companies increasingly explore opportunities within the lucrative nutraceutical market, driven by rising consumer demand for health-enhancing products.

Continue reading